We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.52 | 4.36 | 4.99 | - | 24,733 | 08:00:23 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 25/8/2020 19:14 | >> tickboo Waterloo sends them to Richard.... | nobbygnome | |
| 25/8/2020 18:49 | I'd hope/assume SNG is aware of all the research papers Waterloo finds and puts on the guild. Surely they would give more weight to our fairly small trial size. Every little helps and Waterloo has posted 20+ super papers which reinforce what SNG has. One would also assume the CEO is using these to help our cause and although they would not usually be considered to bi-pass a phase 3 trial we are obviously in exceptional times. | tickboo | |
| 25/8/2020 18:11 | More TR1s on the way to let us know where all these shares (2% churn yesterday, 3.5% today) have found a new home? | sloppyjoe2 | |
| 25/8/2020 17:46 | About 1.6m late reported trades. | wetdream |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
